Home ETFdb.com Valuation Opportunities in China’s Healthcare Sector

Valuation Opportunities in China’s Healthcare Sector

The health care industry in China is expected to expand rapidly in the coming years with a rapidly aging population, growing infrastructure, and China’s growing role in the global health care system through contributions and collaborations that its biotech companies are embarking on. Delisting fears and market volatility have caused a pullback that has resulted in valuation opportunities to buy into a sector that KraneShares believes will experience strong growth in the coming years.

newETFs.io respects the hard work of others and gives all credit to the remarkable folks at ETFdb.com. This excerpt/article was pulled from their RSS feed; click here to view the original. Please note that on occasion, the RSS feed will not have the author. When this happens this site defaults the author to "News". Make no mistake, this excerpt/article was not created by newETFs.io, it was simply shared with you.